BridgeMD
New treatment option for Breast Cancer
Official title IMproving PAtient UndeRstanding of GEP TEst Results: Phase 4
ClinicalTrials.gov ID: NCT06703567
What this study is testing
- What it's testing
- The primary aim of the study is to determine if provision of a patient information film about Oncotype DX improves patients' knowledge and understanding about Gene Expression Profiling (GEP) test and risk of recurrence results in early breast cancer (EBC) patients, identified by their clinical teams as potentially benefiting from having their tumor samples sent for GEP analysis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- First presentation of early stage breast cancer with all known disease surgically removed
- Estrogen Receptor (ER) positive and Human Epidermal growth factor Receptor 2 (HER-2) negative
- No clear decision on whether chemotherapy should be given as adjunct based on current prognostic criteria
- Consented to GEP testing
- Able to give full informed consent to IMPARTER study
You likely can't join if
- Other breast cancer diagnosis (e.g. Ductal carcinoma in situ, Metastatic)
- Unable to give fully informed consent
- Under 18 years of age
- Unable to understand and speak Italian
- No access to internet connection or devices
See the full eligibility criteria
- First presentation of early stage breast cancer with all known disease surgically removed
- Estrogen Receptor (ER) positive and Human Epidermal growth factor Receptor 2 (HER-2) negative
- No clear decision on whether chemotherapy should be given as adjunct based on current prognostic criteria
- Consented to GEP testing
- Able to give full informed consent to IMPARTER study
- Good comprehension of the Italian language
- Access to internet connection and devices (e.g. smart phone, tablet, laptop or desktop computer)
- Other breast cancer diagnosis (e.g. Ductal carcinoma in situ, Metastatic)
- Unable to give fully informed consent
- Under 18 years of age
- Unable to understand and speak Italian
- No access to internet connection or devices
The study team makes the final eligibility decision.
Where it's taking place
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.